Centocor Seeks Continuing Damages Over Humira
By Melissa Lipman · January 4, 2010, 4:36 PM EST
Centocor Ortho Biotech Inc. has filed a new suit against Abbott Laboratories, seeking continuing damages as Abbott appeals a $1.85 billion judgment that its arthritis treatment Humira infringes a patent held...
To view the full article, register now.